Skip to main content

Aldeyra Therapeutics, Inc.

ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001341235

No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Aldeyra Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of ALDX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders101103+2
Shares35.4M35.3M−78.6K (−0.2%)
Value$115.8M$116.9M+$1.10M (+1.0%)

New holders (18)

Institutions that held Aldeyra Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to ALDX in Q2 2024
InstitutionSharesValue% of portfolio
Federated Hermes, Inc.531,221$1.76M0.00%
PFG Investments, LLC396,247$1.31M0.09%
Jane Street Group, LLC93,146$308.3K0.00%
Panagora Asset Management Inc60,298$199.6K0.00%
CIBC Private Wealth Group, LLC51,458$170.3K0.00%
Alps Advisors Inc46,326$153.3K0.00%
Corebridge Financial, Inc.26,802$88.7K0.00%
Mirae Asset Global ETFs Holdings Ltd.24,405$80.8K0.00%
Stifel Financial Corp15,517$51.4K0.00%
Walleye Capital LLC14,168$46.9K0.00%
Diversified Trust Co12,265$40.6K0.00%
SG Americas Securities, LLC11,378$38.0K0.00%
Clearstead Advisors, LLC10,398$34.4K0.00%
Activest Wealth Management2,000$6.62K0.00%
nVerses Capital, LLC1,700$5.63K0.00%
SRS Capital Advisors, Inc.266$8810.00%
Innealta Capital, LLC46$1520.00%
The PNC Financial Services Group, Inc.34$1130.00%

Sold out (16)

Institutions that held Aldeyra Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.